2021
DOI: 10.3389/fonc.2021.769036
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria-Shaping Proteins and Chemotherapy

Abstract: The emergence, in recent decades, of an entirely new area of “Mitochondrial dynamics”, which consists principally of fission and fusion, reflects the recognition that mitochondria play a significant role in human tumorigenesis and response to therapeutics. Proteins that determine mitochondrial dynamics are referred to as “shaping proteins”. Marked heterogeneity has been observed in the response of tumor cells to chemotherapy, which is associated with imbalances in mitochondrial dynamics and function leading to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 128 publications
(158 reference statements)
2
6
0
Order By: Relevance
“…Thus, our study suggests that co-treatment of platinum-based chemotherapies with CHK1 inhibitors, which restore SSBP1 localization to the mitochondria and increase ROS, may be an approach to overcome platinum resistance. Moreover, they suggest a general mechanism of resistance for therapeutic agents whose cytotoxicity is mediated in part by increasing the steady-state levels of nuclear H 2 O 2 and is in accordance with the growing body of evidence that mitochondrial function is a critical determinant of therapeutic response (Fu et al, 2021; Gentric et al, 2019; Shen et al, 2021; Xie et al, 2021).…”
Section: Discussionsupporting
confidence: 75%
“…Thus, our study suggests that co-treatment of platinum-based chemotherapies with CHK1 inhibitors, which restore SSBP1 localization to the mitochondria and increase ROS, may be an approach to overcome platinum resistance. Moreover, they suggest a general mechanism of resistance for therapeutic agents whose cytotoxicity is mediated in part by increasing the steady-state levels of nuclear H 2 O 2 and is in accordance with the growing body of evidence that mitochondrial function is a critical determinant of therapeutic response (Fu et al, 2021; Gentric et al, 2019; Shen et al, 2021; Xie et al, 2021).…”
Section: Discussionsupporting
confidence: 75%
“…Finally, the upregulation of mitochondrial proteins involved both in ATP production and drug resistance [9], and/or immune-resistance [10] could lead to new therapies. In parallel, all these studies could also shed light on new biomarkers for better predictions of cancer chemosensitivity [11].…”
Section: Introductionmentioning
confidence: 93%
“…OPA-1, along with Drp-1 play critical roles in preserving mitochondrial morphology and function. They are recognized as "mitochondria-shaping" proteins, responsible for mitochondria dynamic regulation through a careful balance between fission and fusion events [55]. Down-regulation of OPA-1, together with up-regulation of Drp-1, favor mitochondria fragmentation and cristae remodeling, facilitating the release of cytochrome c triggered by apoptotic stimuli [56,57].…”
Section: Plos Onementioning
confidence: 99%